Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells
2009 · Breast Cancer Research · 87 citations
https://doi.org/10.1186/bcr2231
T
Tamotsu Sudo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
119
Papers
2.3K
Citations
23
h-index
44
i10-index
Tamotsu Sudo is an academic researcher from Fujita Health University. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Cancer Research and Treatments & Ovarian cancer diagnosis and treatment. The author has an h-index of 23, co-authored 102 publications.
Papers by this author
worksAbsence of Human Papillomavirus Infection and Activation of PI3K-AKT Pathway in Cervical Clear Cell Carcinoma
2013 · International Journal of Gynecological Cancer · 68 citations
https://doi.org/10.1097/igc.0b013e3182981bdc
Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy
2011 · Scientific Reports · 59 citations
https://doi.org/10.1038/srep00180
Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer
2014 · Breast Cancer Research and Treatment · 21 citations
https://doi.org/10.1007/s10549-014-3121-5
Correlative expression of cyclooxygenase-1 (Cox-1) and human epidermal growth factor receptor type-2 (Her-2) in endometrial cancer.
2007 · PubMed · 16 citations
https://doi.org/10.24546/81000117
Immunohistochemical expression of CD44v9 and 8‐OHdG in ovarian endometrioma and the benign endometriotic lesions adjacent to clear cell carcinoma
2019 · Journal of obstetrics and gynaecology research · 11 citations
https://doi.org/10.1111/jog.14093
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat